Supply Chain and Quality Operations in Ireland

New Dublin Facility Will Serve Patients with Life-Threatening Ultra-Rare Disorders in 50 Countries

Dublin - The Minister for Jobs, Enterprise and Innovation Richard Bruton, TD today announced that Alexion Pharmaceuticals is expanding its global presence with the opening of a new office and laboratory facility in Dublin in conjunction with the company’s decision to establish a global supply chain facility in Ireland.  Alexion has begun the process of recruiting approximately 50 employees by year-end for a range of initial positions in its supply chain, quality assurance, quality control and logistics functions by year-end.

Alexion’s new, additional global supply chain and quality staff in Ireland are expected to begin supplying Soliris® (eculizumab) to patients with PNH and aHUS, two severe and life-threatening ultra-rare disorders, by the end of 2013.  The company’s expanding Irish workforce will also manage the supply of additional Alexion medicines to patients following regulatory approvals for a series of anticipated launches of new therapies over the next several years. Today’s announcement is supported by the Department of Jobs, Enterprise and Innovation through IDA Ireland.

Read full press release here